VP, Program Team Leader
Dyne Therapeutics
About this role
Dyne Therapeutics is developing therapeutics targeting muscle and the central nervous system for genetically driven neuromuscular diseases, with ongoing programs in diseases like DMD and DM1. The company is focused on delivering transformative medicines and pioneering clinical programs.
Skills
About Dyne Therapeutics
dyne-tx.comDyne Therapeutics is a biotechnology company developing nucleic acid–based therapies for rare, inherited muscle diseases. With the mission "Repairing muscle, reclaiming now," it aims to create life‑transforming medicines that restore muscle function and improve patients' lives. Dyne advances programs from discovery into clinical development with a focus on genetic muscle disorders (including various muscular dystrophies) and works with partners to accelerate delivery of therapies to patients.
Recent company news
MarketBeatDyne Therapeutics, Inc. $DYN Shares Acquired by Vanguard Group Inc.
9 hours ago
Simply Wall StreetA Look At Dyne Therapeutics (DYN) Valuation As Late Stage Pipeline And BLA Plans Gain Momentum
17 hours ago
GlobeNewswireDyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
2 days ago
AOL.comInvestment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing
11 hours ago
NasdaqDyne Therapeutics Posts Wider Loss In Q4
2 days ago
About Dyne Therapeutics
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Dyne Therapeutics.
Salary
$288k – $350k
per year